Literature DB >> 21671375

Desmosterolosis-phenotypic and molecular characterization of a third case and review of the literature.

Christian P Schaaf1, Janet Koster, Panagiotis Katsonis, Lisa Kratz, Oleg A Shchelochkov, Fernando Scaglia, Richard I Kelley, Olivier Lichtarge, Hans R Waterham, Marwan Shinawi.   

Abstract

Desmosterolosis, a rare disorder of cholesterol biosynthesis, is caused by mutations in DHCR24, the gene encoding the enzyme 24-dehydrocholesterol reductase (DHCR24). To date, desmosterolosis has been described in only two patients. Here we report on a third patient with desmosterolosis who presented after delivery with relative macrocephaly, mild arthrogryposis, and dysmorphic facial features. Brain MRI revealed hydrocephalus, thickening of the tectum and massa intermedia, mildly effaced gyral pattern, underopercularization, and a thin corpus callosum. The diagnosis of desmosterolosis was established by detection of significant elevation of plasma desmosterol levels and reduced enzyme activity of DHCR24 upon expression of the patient's DHCR24 cDNA in yeast. The patient was found to be a compound heterozygote for c.281G>A (p.R94H) and c.1438G>A (p.E480K) mutations. Structural and evolutionary analyses showed that residue R94 resides at the flavin adenine dinucleotide (FAD) binding site and is strictly conserved throughout evolution, while residue E480 is less conserved, but the charge shift substitution is accompanied by drastic changes in the local protein environment of that residue. We compare the phenotype of our patient with previously reported cases.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671375      PMCID: PMC4995031          DOI: 10.1002/ajmg.a.34040

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  34 in total

1.  Generation of viable cholesterol-free mice.

Authors:  A Wechsler; A Brafman; M Shafir; M Heverin; H Gottlieb; G Damari; S Gozlan-Kelner; I Spivak; O Moshkin; E Fridman; Y Becker; R Skaliter; P Einat; A Faerman; I Björkhem; E Feinstein
Journal:  Science       Date:  2003-12-19       Impact factor: 47.728

2.  Eventration of the diaphragm and associations.

Authors:  M L Kulkarni; B Sneharoopa; H N Vani; Sarfaraz Nawaz; B Kannan; Preethi M Kulkarni
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 1.967

3.  DHCR24 gene knockout mice demonstrate lethal dermopathy with differentiation and maturation defects in the epidermis.

Authors:  Rusella Mirza; Shizu Hayasaka; Yoshiko Takagishi; Fukushi Kambe; Sachiko Ohmori; Kazuko Maki; Michiyo Yamamoto; Kohji Murakami; Takahide Kaji; David Zadworny; Yoshiharu Murata; Hisao Seo
Journal:  J Invest Dermatol       Date:  2006-03       Impact factor: 8.551

4.  Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)

Authors:  E R Elias; M B Irons; A D Hurley; G S Tint; G Salen
Journal:  Am J Med Genet       Date:  1997-01-31

Review 5.  The Smith-Lemli-Opitz syndrome.

Authors:  R I Kelley; R C Hennekam
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

6.  Clinical phenotype of desmosterolosis.

Authors:  D R FitzPatrick; J W Keeling; M J Evans; A E Kan; J E Bell; M E Porteous; K Mills; R M Winter; P T Clayton
Journal:  Am J Med Genet       Date:  1998-01-13

Review 7.  Role of cholesterol in synapse formation and function.

Authors:  Frank W Pfrieger
Journal:  Biochim Biophys Acta       Date:  2003-03-10

8.  Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome.

Authors:  Darryn M Sikora; Mark Ruggiero; Kersti Petit-Kekel; Louise S Merkens; William E Connor; Robert D Steiner
Journal:  J Pediatr       Date:  2004-06       Impact factor: 4.406

9.  Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome.

Authors:  Yen-Ming Chan; Louise S Merkens; William E Connor; Jean-Baptiste Roullet; Jennifer A Penfield; Julia M Jordan; Robert D Steiner; Peter J H Jones
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

10.  The PDAC syndrome (pulmonary hypoplasia/agenesis, diaphragmatic hernia/eventration, anophthalmia/microphthalmia, and cardiac defect) (Spear syndrome, Matthew-Wood syndrome): report of eight cases including a living child and further evidence for autosomal recessive inheritance.

Authors:  David Chitayat; Hana Sroka; Sarah Keating; Randall S Colby; Greg Ryan; Ants Toi; Susan Blaser; Sandra Viero; Louise Devisme; Odile Boute-Bénéjean; Sylvie Manouvrier-Hanu; Geert Mortier; Bart Loeys; Anita Rauch; Pierre Bitoun
Journal:  Am J Med Genet A       Date:  2007-06-15       Impact factor: 2.802

View more
  20 in total

1.  The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts.

Authors:  Zeljka Korade; Hye-Young H Kim; Keri A Tallman; Wei Liu; Katalin Koczok; Istvan Balogh; Libin Xu; Karoly Mirnics; Ned A Porter
Journal:  J Med Chem       Date:  2016-01-29       Impact factor: 7.446

Review 2.  Radiographic features of the skeleton in disorders of post-squalene cholesterol biosynthesis.

Authors:  Massimiliano Rossi; Christine M Hall; Raymonde Bouvier; Sophie Collardeau-Frachon; Frédérique Le Breton; Martine Bucourt; Marie Pierre Cordier; Christine Vianey-Saban; Giancarlo Parenti; Generoso Andria; Martine Le Merrer; Patrick Edery; Amaka C Offiah
Journal:  Pediatr Radiol       Date:  2015-02-03

3.  Desmosterolosis presenting with multiple congenital anomalies.

Authors:  Mersedeh Rohanizadegan; Stephanie Sacharow
Journal:  Eur J Med Genet       Date:  2017-11-23       Impact factor: 2.708

Review 4.  Genetic alterations affecting cholesterol metabolism and human fertility.

Authors:  Anthony M DeAngelis; Meaghan Roy-O'Reilly; Annabelle Rodriguez
Journal:  Biol Reprod       Date:  2014-08-13       Impact factor: 4.285

5.  Desmosterolosis and desmosterol homeostasis in the developing mouse brain.

Authors:  Luke B Allen; Thiago C Genaro-Mattos; Ned A Porter; Károly Mirnics; Zeljka Korade
Journal:  J Inherit Metab Dis       Date:  2019-04-08       Impact factor: 4.982

6.  Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.

Authors:  Frances M Platt; Christopher Wassif; Alexandria Colaco; Andrea Dardis; Emyr Lloyd-Evans; Bruno Bembi; Forbes D Porter
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

Review 7.  Heritable disorders in the metabolism of the dolichols: A bridge from sterol biosynthesis to molecular glycosylation.

Authors:  Lynne A Wolfe; Eva Morava; Miao He; Jerry Vockley; K Michael Gibson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-10-11       Impact factor: 3.908

Review 8.  From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D.

Authors:  John T Pinto; Arthur J L Cooper
Journal:  Adv Nutr       Date:  2014-03-01       Impact factor: 8.701

9.  Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis.

Authors:  Winnie Luu; Eser J Zerenturk; Ika Kristiana; Martin P Bucknall; Laura J Sharpe; Andrew J Brown
Journal:  J Lipid Res       Date:  2013-12-20       Impact factor: 5.922

Review 10.  Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.

Authors:  Melissa D Svoboda; Jill M Christie; Yasemen Eroglu; Kurt A Freeman; Robert D Steiner
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-10-05       Impact factor: 3.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.